MARSHALL WACE, LLP - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 94 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$22,490
-23.7%
24,9880.0%0.00%
Q4 2022$29,486
-89.7%
24,988
-27.2%
0.00%
-100.0%
Q1 2022$285,000
-59.2%
34,313
-60.0%
0.00%
-75.0%
Q3 2020$698,000
+36.3%
85,691
+60.7%
0.00%0.0%
Q2 2020$512,000
-11.0%
53,315
-36.9%
0.00%
-33.3%
Q1 2020$575,000
+945.5%
84,538
+1490.6%
0.01%
Q3 2019$55,0005,3150.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Simplify Asset Management Inc. 2,700,000$823,5000.09%
683 Capital Management, LLC 2,650,000$808,2500.06%
GSA CAPITAL PARTNERS LLP 355,867$1090.01%
RBF Capital, LLC 391,265$119,3360.01%
UBS OCONNOR LLC 393,975$120,1620.00%
XTX Topco Ltd 15,597$4,7570.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 106,700$32,5440.00%
AMERIPRISE FINANCIAL INC 8,592,471$2,620,7040.00%
DRW Securities, LLC 120,365$370.00%
DFPG INVESTMENTS, LLC 32,430$10,8960.00%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders